financetom
Business
financetom
/
Business
/
Nazara Technologies to use cash boost for organic growth
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Nazara Technologies to use cash boost for organic growth
Oct 6, 2023 6:03 AM

Following a successful fund raising, Nazara Technologies has a cash balance of around Rs 1,200-1,300 crore on its balance sheet and the company plans to use it for organic expansion, Nitish Mittersain, Joint MD & CEO of Nazara Technologies told CNBC-TV18.

Share Market Live

NSE

He said, “We have always been very acquisitive. At this point in time, we see a lot of value opportunities where we believe can acquire businesses and significantly scale them both in terms of their revenue, margins, and profitability."

Mittersain said the company is looking for companies having revenues of at least around Rs 100 crore.

The gaming and sports media platform, Nazara Technologies, successfully raised more than Rs 500 crore from SBI Mutual Fund and Zerodha's Kamath brothers.

In September, Nazara Tech's board approved the issuance of 57.42 lakh shares valued at Rs 410 crore to SBI Mutual Fund at a rate of Rs 714 per share through a preferential allocation.

Out of the total Rs 410 crore, Rs 200 crore worth of shares will be allocated to SBI Multicap, Rs 120 crore to SBI Magnum Global Fund, and Rs 90 crore to SBI Tech Opportunities.

Additionally, 14 lakh shares worth Rs 100 crore were also allotted to Nikhil Kamath.

On the imposition of goods and services tax (GST) on real money gaming business, he said, “It is not a very large business for us and therefore, any impact on that business is relatively less material for our overall financial performance.”

“From October 1, the new GST applicability has come in place and we have complied with that,” he added.

He believes the business will take a short-term hit in terms of profitability.

“We are looking at this particular segment of our business as a glass half full rather than half empty kind of perspective,” he stated.

The company will look at more aggressive investments going forward in this segment.

For more details, watch the accompanying video

(Edited by : Shweta Mungre)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Fidelis Insurance Q3 premiums written rises
Fidelis Insurance Q3 premiums written rises
Nov 12, 2025
Overview * Fidelis Q3 gross premiums written grow 7.5% yr/yr * Combined ratio improves to 79.0% from 87.4% in Q3 2024 * Net income for Q3 was $130.5 mln Outlook * Fidelis targets 6-10% growth in gross premiums written for full-year 2025 * Fidelis focused on expanding underwriting partnerships amid rate pressure Result Drivers * GROSS PREMIUMS GROWTH - GPW...
Canadian spirits company Corby's Q1 revenue up 16% to record $75.4 mln
Canadian spirits company Corby's Q1 revenue up 16% to record $75.4 mln
Nov 12, 2025
Overview * Corby Q1 fiscal 2026 revenue grows 16% yr/yr, reaching an all-time high of C$75.4 mln * Adjusted EBITDA for Q1 reaches record C$20.3 mln, up 4% yr/yr * Adjusted net earnings for Q1 rise 8% yr/yr to C$11 mln Outlook * Company anticipates softer Q2 due to low comparative base and BCGEU strike impact * Corby expects full-year...
United Therapeutics Insider Sold Shares Worth $3,600,830, According to a Recent SEC Filing
United Therapeutics Insider Sold Shares Worth $3,600,830, According to a Recent SEC Filing
Nov 12, 2025
04:43 PM EST, 11/12/2025 (MT Newswires) -- Martine A Rothblatt, Director, Chairperson & CEO, on November 10, 2025, sold 8,000 shares in United Therapeutics ( UTHR ) for $3,600,830. Following the Form 4 filing with the SEC, Rothblatt has control over a total of 644,489 common shares of the company, with 130 shares held directly and 644,359 controlled indirectly. SEC...
Health and wellness company Mannatech's Q3 net sales down 8.1%
Health and wellness company Mannatech's Q3 net sales down 8.1%
Nov 12, 2025
Overview * Mannatech Q3 2025 net sales decline 8.1% yr/yr due to slowing regional demand * Co reports net income of $1.9 mln from a net loss last year * Gross profit margin increases to 76.4% in Q3 2025 due to higher sales prices Outlook * Company notes trade policy changes could impact cost structure and profitability * Company faces...
Copyright 2023-2026 - www.financetom.com All Rights Reserved